Medindia2d
Chronic Lymphocytic Leukemia: Acalabrutinib–Venetoclax Vs. Chemoimmunotherapy
Acalabrutinib–Venetoclax improves progression-free survival and reduces disease progression in untreated chronic lymphocytic ...
Early detection of childhood blood cancer can save lives: Signs and symptoms every parent should know
Leukemia is a leading cause of death among children in India, with over 30,000 cases diagnosed annually. Early diagnosis is ...
Medscape3d
Lymphoma Expert Blends Bedside and Trial Work
New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.
Targeted Oncology18h
Jain and Participants Consider BTK Inhibitor Resistance in CLL
During a Case-Based Roundtable® event, Nitin Jain, MD, and participants discussed treating a patient with CLL after ...
mp.pl1d
Increased turnover of non-malignant T lymphocytes in patients with chronic lymphocytic leukemia may affect clinical progression
Introduction: A unique feature of chronic lymphocytic leukemia (CLL) is the increased number of circulating T cells preventing malignant B cells from undergoing apoptosis. Dysregulated expression of ...
Galapagos downgraded at Morgan Stanley on new pipeline focus
Shares of Galapagos (NASDAQ:GLPG) (OTCPK:GLPGF) ended a four-day winning streak on Friday after Morgan Stanley downgraded the Belgian biotech, citing its decision to deprioritize its CAR-T therapy ...